Gain Therapeutics, Inc.
Pharmaceutical company · Bethesda, Maryland, United States · Nasdaq: GANX
Gain Therapeutics, Inc. is a pharmaceutical company headquartered in Bethesda, Maryland, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker GANX. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2020.
Gain Therapeutics at a glance
What does Gain Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $10 million sold (2020).
Frequently asked questions about Gain Therapeutics
Where is Gain Therapeutics headquartered?
Gain Therapeutics, Inc. is headquartered in Bethesda, Maryland, United States.
What does Gain Therapeutics do?
Gain Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Gain Therapeutics a public company?
Yes. Gain Therapeutics, Inc. trades on Nasdaq under the ticker GANX.
When was Gain Therapeutics founded?
The earliest incorporation on record for Gain Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.